SENSORCAINE MPF
Generic: BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, BUPIVACAINE HYDROCHLORIDE
Fresenius Kabi USAManufacturer
EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL, RETROBULBARRoute
BUPIVACAINE HYDROCHLORIDEActive Substance
1981-12-30Original Approval
SENSORCAINE MPF is FDA application NDA018304, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
653 reports
2
ANAESTHETIC COMPLICATION
215 reports
3
MUSCULOSKELETAL PAIN
202 reports
4
MATERNAL EXPOSURE DURING PREGNANCY
196 reports
5
OFF LABEL USE
180 reports
6
HYPOAESTHESIA
152 reports
7
HYPOTENSION
128 reports
8
CONDITION AGGRAVATED
126 reports
9
JOINT INJURY
126 reports
10
DYSPNOEA
122 reports